JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

301093

CNE100004YH2

Tires & Rubber Products

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-21 EDT			5-day change	1st Jan Change
22.84 ^CNY	+1.87%		+1.60%	-29.29%

04-25	Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-21	Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021

May 23, 2022 at 03:40 pm

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. at the AGM held on May 20, 2022, approved Cash dividend per 10 shares (tax included) of CNY 7.00000000 for 2021.

Latest news about Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-21	CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.	03-21	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.	03-10	CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.	01-02	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-22	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.	23-07-02	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023	23-06-28	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023.	23-06-05	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-17	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022	23-04-24	CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-23	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.	22-07-20	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022	22-05-27	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021	22-05-23	CI
Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period	22-05-08	MT
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Profit Distribution Proposal for 2021	22-04-25	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Executive Changes	22-03-23	CI

Chart Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Duration

Period

Chart Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

More charts

Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for direct contact injection drugs. The Companyâs main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The Company's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The Company also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The Company distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.

Sector

Tires & Rubber Products

Calendar

2024-06-06 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.84 CNY

Average target price

43.78 CNY

Spread / Average Target

+91.68%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Tires & Rubber Products

	1st Jan change	Capi.
JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.	-29.29%	406M
BRIDGESTONE CORPORATION	+17.16%	29.87B
MICHELIN (CGDE)	+12.69%	28.08B
SAILUN GROUP CO., LTD.	+31.74%	6.74B
THE YOKOHAMA RUBBER CO., LTD.	+25.02%	4.17B
DÄTWYLER HOLDING AG	+0.72%	3.62B
VIETNAM RUBBER INDUSTRY GROUP -	+54.72%	3.58B
THE GOODYEAR TIRE & RUBBER COMPANY	-12.29%	3.58B
SUMITOMO RUBBER INDUSTRIES, LTD.	+15.21%	2.99B
TOYO TIRE CORPORATION	+15.87%	2.69B

Other Tires & Rubber Products